2014
DOI: 10.5935/0103-5053.20140138
|View full text |Cite
|
Sign up to set email alerts
|

Leishmanicidal Activity ofBrosimum glaziovii(Moraceae) and Chemical Composition of the Bioactive Fractions by Using High-Resolution Gas Chromatography and GC-MS

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
5
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 0 publications
0
5
0
Order By: Relevance
“…The use of the fingerstick test has shown good reproducibility (0.958 glucose, triglycerides 0.992, 0.940 total cholesterol) and high correlation with the laboratory method (glucose 0.952, 0.990 triglycerides, and total cholesterol 0.944). These results demonstrate the method is feasible for portable conducting research and as an alternative to the monitoring of metabolic disease and cardiovascular risk factors (COQUEIRO et al, 2014;EIZERIK, 2012).…”
Section: Discussionmentioning
confidence: 91%
“…The use of the fingerstick test has shown good reproducibility (0.958 glucose, triglycerides 0.992, 0.940 total cholesterol) and high correlation with the laboratory method (glucose 0.952, 0.990 triglycerides, and total cholesterol 0.944). These results demonstrate the method is feasible for portable conducting research and as an alternative to the monitoring of metabolic disease and cardiovascular risk factors (COQUEIRO et al, 2014;EIZERIK, 2012).…”
Section: Discussionmentioning
confidence: 91%
“…Several synthetic and natural products have been explored in order to discover new antileishmanial/antibacterial drugs [9][10][11][12][13][14][15][16][17][18][19][20][21]. In general, the process of drug discovery relies on the identification of bioactive compounds that target biochemical and metabolic pathways that are essential for pathogens viability and infectivity.…”
Section: Introductionmentioning
confidence: 99%
“…The cutaneous form of the disease is the most common manifestation, presenting an annual incidence of 0.7 to 1.3 million new cases [2,3]. The available therapeutic drugs for leishmaniasis treatment are still based on pentavalent antimonials, amphotericin B, miltefosine or paromomycin, which present several limitations such as toxicity, difficult route of administration and variable efficacy [4], and although many efforts have been made towards the discovery of new synthetic or natural antileishmanials [5][6][7][8][9][10][11][12], new therapeutic options are still needed. In recent years, photodynamic therapy (PDT) has been investigated as a potential alternative to control cutaneous leishmaniasis (CL) [13][14][15][16].…”
Section: Introductionmentioning
confidence: 99%